Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Yekaterina Karpitskaya

Orthopaedic Surgery Biloxi, MS Medical Doctor

NPI 1932223542 CMS profile 503940

1720A Medical Park Dr, Suite 220, Biloxi, MS 39532

Open in the dashboard

General payments

$9,199

86 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Yekaterina Karpitskaya of Biloxi, MS is reported in the CMS Open Payments database as having received $9,199 across 86 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 68th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $548 11
2024 General $1,513 17
2023 General $1,131 16
2022 General $5,149 25
2021 General $458 5
2020 General $165 5
2019 General $235 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Yekaterina Karpitskaya
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Yekaterina Karpitskaya were reported at $548. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Yekaterina Karpitskaya Orthopaedic Surgery median Middle half National median
2019 $235 $644 $140–$2,844 $163
2020 $165 $312 $75–$1,860 $114
2021 $458 $520 $117–$2,495 $132
2022 $5,149 $598 $128–$2,731 $149
2023 $1,131 $461 $128–$2,264 $160
2024 $1,513 $497 $134–$2,475 $164
2025 $548 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $4,324 30 payments
  2. Alon Medical Technology $2,439 10 payments
  3. DePuy Synthes Sales Inc. $621 9 payments
  4. Sanara MedTech Inc. $582 4 payments
  5. Smith+Nephew, Inc. $362 2 payments
  6. Bioventus LLC $256 7 payments
  7. Flexion Therapeutics, Inc. $138 3 payments
  8. Stryker Corporation $133 1 payment
  9. Vericel Corporation $81 4 payments
  10. Horizon Therapeutics plc $72 5 payments
  11. Other $191 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $3,614 4 payments
  2. Food and Beverage $3,218 75 payments
  3. Travel and Lodging $2,161 6 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $206 1 payment
Products named General payments · program years 2019–2025
  1. CellerateRx $470 3 payments
  2. TSS $206 1 payment
  3. NA Trauma $201 2 payments
  4. Durolane $185 3 payments
  5. Regeneten $156 1 payment
  6. Zilretta $138 3 payments
  7. INSPACE $133 1 payment
  8. NA Orthopedics $117 2 payments
  9. ACTIS $116 1 payment
  10. VA-LCP $116 1 payment
  11. Other $1,055 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 18 drugs

Part D claims

1,064

Median for Orthopedic Surgery: 203

Drug cost

$12,660

Median for Orthopedic Surgery: $1,433

Branded share of claims

31.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 15 $6,454
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 155 $1,470
Celecoxib Generic 52 $1,028
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 125 $1,013
Meloxicam Generic 357 $808
Tizanidine Hcl Generic 43 $251
Methylprednisolone Generic 38 $238
Methocarbamol Generic 11 $213
Gabapentin Generic 42 $189
Ondansetron Odt Ondansetron Brand 27 $187

The 10 drugs with the highest cost, of 18 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 124 billing codes

Paid by Medicare

$173,215

Of which drugs: $22,191

Medicare patients

423

Average age 74

Services billed

9,220

267 women, 156 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 30%
Ischemic heart disease 28%
Depression 27%
Chronic kidney disease 24%
Osteoporosis 23%
Heart failure 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose J7323 Office 29 108 $9,806
Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg J7318 Office 16 1,620 $8,178
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 175 2,328 $1,587
Injection, methylprednisolone acetate, 1 mg J1010 Office 36 2,924 $294
Injection, ketorolac tromethamine, per 15 mg J1885 Office 27 189 $98

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

86 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record